Neurogenomics – News and Features

Researchers have uncovered a novel mechanism underlying memory formation that involves rapid changes to DNA structure.

Findings from the largest genetic study of PTSD to date could help explain why only some people develop the condition after experiencing trauma.

Recently approved Alzheimer's drugs work by tagging amyloid plaques for clearance by the brain's microglia. Washington University School of Medicine in St. Louis researchers are developing an alternative approach, using a homemade antibody to directly mobilize microglia.

A new study revealed that Alzheimer's disease starts earlier and progresses faster in people with Down syndrome, which could have important implications for their treatment and care.

A new study from Van Andel Institute scientists offers a first look into the complex molecular changes that occur in brain cells with Lewy bodies, which are key pathological hallmarks of Parkinson’s disease and some dementias.

An international team of scientists has published the first single-cell atlas forPristina leidyi (Pristina), a segmented annelid with extraordinary regenerative abilities that has fascinated biologists for more than a century.

Here, we highlight some of the latest advancements in vitamin A research working to address its effects on human health.

Why are some people right-handed, while others are left-handed? A new study has found left-handed people carry a specific genetic variation at a higher rate than righties.

Inside the brains of people with psychosis, two key systems are malfunctioning: a “filter” that directs attention toward important events and thoughts, and a “predictor” composed of pathways that anticipate rewards.

Columbia researchers have discovered a genetic variant that reduces the odds of developing Alzheimer’s disease by up to 70% and may be protecting thousands of people in the United States from the disease.